# US 2021/0277475 A1 · MicroRNA Biomarkers for Traumatic Brain Injury and Methods of Use Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277475 A1
- Document ID: US20210277475A1
- Status: Published application
- Kind: A1
- Application number: 17/225,653
- Filed: 2021-04-08
- Published: 2021-09-09
- Earliest claimed: 2015-07-29
- Assignees: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; University of Florida Research Foundation, Inc.; Orlando Health, Inc., d/b/a Orlando Regional Medical Center
- Applicants: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; University of Florida Research Foundation, Inc.; Orlando Health, Inc., d/b/a Orlando Regional Medical Center
- Inventors: Radha K. MAHESHWARI; Nagaraja S. BALAKATHIRESAN; Manish BHOMIA; Kevin K. WANG; Linda PAPA
- Web page: https://patentgrep.com/patent/US20210277475A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/118: Prognosis of disease development
- C12Q 2600/178: miRNA, siRNA or ncRNA
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention relates to methods of diagnosing traumatic brain injury (TBI) in a subject. The present invention also relates to methods of monitoring the progression of the TBI in a subject.

## Claims

### Claim 1

A method of diagnosing traumatic brain injury (TBI) in a subject, the method comprising
a) determining a level(s) of one or more micro RNAs (miRNAs) comprising hsa-miR-151-5p and/or miR-9* in a biological sample taken from the subject, and
b) comparing the determined level(s) of the one or more miRNAs against a level(s) of the same one or more miRNAs from a control subject determined not to be suffering from TBI,
wherein an increase in the level(s) of the one or more miRNAs compared to the level(s) of the one or more miRNAs-from the control subject determined not to be suffering from TBI is indicative that the subject is suffering from TBI.

### Claim 2 (depends on 1)

The method of claim 1, further comprising measuring the level of one or more additional miRNAs comprising hsa-miR-328, hsa-miR-362-3p, hsa-miR-486, hsa-miR-942, hsa-miR-194, hsa-miR-361, hsa-miR-625*, hsa-miR-1255B, hsa-miR-381, hsa-miR-425*, hsa-miR-638, hsa-miR-93, hsa-miR-1291, hsa-miR-19a, hsa-miR-601, hsa-miR-660, hsa-miR-130b, hsa-miR-339-3p, hsa-miR-34a, hsa-miR-455, hsa-miR-579, hsa-miR-624, mmu-miR-491, hsa-miR-195, hsa-miR-30d, hsa-miR-20a, hsa-miR-505*, mmu-miR-451, hsa-miR-199a-3p, hsa-miR-27a, hsa-miR-27b, hsa-miR-296, hsa-miR-92a and hsa-miR-29c.

### Claim at position 3

-5. (canceled)

### Claim 6 (depends on 1)

The method of claim 1, wherein the TBI is mild TBI (mTBI) or severe TBI (sTBI).

### Claim at position 5

-10. (canceled)

### Claim 11 (depends on 1)

The method of claim 1, wherein the TBI is a closed head injury (CHI) or a blast-induced traumatic brain injury (bTBI).

### Claim 12 (depends on 1)

The method of claim 1, wherein the subject is human.

### Claim 13 (depends on 1)

The method of claim 1, wherein the biological sample is a serum sample or a cerebrospinal fluid sample.

### Claim 14 (depends on 1)

The method of claim 1, wherein the biological sample is taken from the subject less than a day after a suspected traumatic episode.

### Claim 15 (depends on 1)

The method of claim 1, wherein the biological sample is taken from the subject less than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, or -14 days after the suspected traumatic episode.

### Claim 16 (depends on 1)

The method of claim 1, wherein the subject is at risk of suffering from TBI.

### Claim 17 (depends on 1)

The method of claim 1, wherein the level(s) of the one or more micro RNAs are determined by a real time PCR.

### Claim 18 (depends on 1)

The method of claim 1, wherein the level(s) of the one or more micro RNAs are measured after normalization with hsa-miR-202.

### Claim 19

(canceled)

### Claim 20

A method of monitoring the progression of traumatic brain injury (TBI) in a subject, the method comprising
a) analyzing at least two biological samples from the subject taken at different time points to determine a level(s) of one or more micro RNAs (miRNAs) comprising hsa-miR-151-5p and/or miR-9* in each of the at least two biological samples, and
b) comparing the determined level(s) of the one or more miRNAs over time to determine if the subject's level(s) of the one or more miRNAs is changing over time,
wherein an increase in the level(s) of the one or more miRNAs over time is indicative that the subject's risk of suffering from TBI is increasing over time.

### Claim 21 (depends on 20)

The method of claim 20, further comprising determining the level(s) of one or more additional miRNAs comprising hsa-miR-328, hsa-miR-362-3p, hsa-miR-486, hsa-miR-942, hsa-miR-194, hsa-miR-361, hsa-miR-625*, hsa-miR-1255B, hsa-miR-381, hsa-miR-425*, hsa-miR-638, hsa-miR-93, hsa-miR-1291, hsa-miR-19a, hsa-miR-601, hsa-miR-660, hsa-miR-130b, hsa-miR-339-3p, hsa-miR-34a, hsa-miR-455, hsa-miR-579, hsa-miR-624, mmu-miR-491, hsa-miR-195, hsa-miR-30d, hsa-miR-20a, hsa-miR-505*, mmu-miR-451, hsa-miR-199a-3p, hsa-miR-27a, hsa-miR-27b, hsa-miR-296, hsa-miR-92a, and/or hsa-miR-29c.

### Claim at position 17

-24. (canceled)

### Claim 25 (depends on 20)

The method of claim 20, wherein the TBI is mild TBI (mTBI) or severe TBI (sTBI).

### Claim at position 19

-29. (canceled)

### Claim 30 (depends on 20)

The method of claim 20, wherein the TBI is a closed head injury (CHI) or a blast-induced traumatic brain injury (bTBI).

### Claim 31 (depends on 20)

The method of claim 20, wherein the subject is human.

### Claim 32 (depends on 20)

The method of claim 20, wherein the biological sample is a serum sample or a cerebrospinal fluid sample.

### Claim 33 (depends on 20)

The method of claim 20, wherein the biological sample is taken from the subject less than a day after a suspected traumatic episode.

### Claim 34 (depends on 20)

The method of claim 20, wherein at least one of the biological samples is taken from the subject less than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, or 14 days after the suspected traumatic episode.

### Claim 35 (depends on 20)

The method of claim 20, wherein the subject is at risk of suffering from TBI.

### Claim 36 (depends on 20)

The method of claim 20, wherein the level(s) of one or more specific micro RNAs are determined by a real time PCR.

### Claim 37 (depends on 20)

The method of claim 20, wherein the level(s) of one or more specific micro RNAs are measured after normalization with hsa-miR-202.

### Claim 38

(canceled)

### Claim 39

A method of detecting a microRNA or plurality of microRNA's in a biological sample, comprising:
obtaining a first biological sample from a subject presenting with or without clinical symptoms of a traumatic brain injury;
contacting said first biological sample with a probe for binding at least one microRNA comprising hsa-miR-151-5p and/or hsa-miR-9*, to produce an microRNA-cDNA protein complex, and
detecting the presence or absence of the microRNA-cDNA complex, wherein the absence of the complex is indicative of the absence of the microRNA in the first biological sample.

### Claim 40 (depends on 39)

The method of claim 39, wherein the probe is detectably labeled.

### Claim 41 (depends on 39)

The method of claim 39, wherein said biological sample is blood, serum, plasma, cerebrospinal fluid, urine, saliva or tissue.

### Claim 42 (depends on 39)

The method of claim 39, wherein said biological sample is obtained less than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14 days after the suspected traumatic episode after said subject suffers a traumatic brain injury.

### Claim 43 (depends on 39)

The method of claim 39, further comprising:
obtaining a biological sample from said subject at a second time point;
contacting said biological sample from said second time point with a probe for binding at least one microRNA comprising hsa-miR-151-5p and/or hsa-miR-9* to produce an microRNA-cDNA complex; and detecting the presence or absence of the microRNA-cDNA complex in said biological sample from said second time point to track the progression of the traumatic brain injury in the subject.

### Claim 44

(canceled)

### Claim 45

A method of detecting one or more microRNA (miRNA) in a human subject with a head injury, the method comprising:
(a) obtaining a serum, saliva, or cerebrospinal fluid biological sample from the human subject,
(b) measuring the level of one or more miRNA comprising hsa-miR-151-5p and/or miR-9* in the serum, saliva, or cerebrospinal fluid biological sample, and
(c) generating a recommendation for a computed tomography (CT) scan of the subject's head if the level of hsa-miR-151-5p and/or miR-9* has an increase of four-fold or more compared to a level of hsa-miR-151-5p and/or miR-9* in a biological sample from a human control subject determined not to be suffering from TBI;
wherein an increase of up to about 10 fold in the level of hsa-miR-151-5p and/or miR-9* compared to the level of hsa-miR-151-5p and/or miR-9* in a biological sample from a human control subject determined not to be suffering from TBI indicates that the human subject with the head injury is suffering from mild TBI, and an increase of between about 10 fold and about 15 fold in the level of hsa-miR-151-5p and/or miR-9* compared to the level of hsa-miR-151-5p and/or miR-9* in a biological sample from a human control subject determined not to be suffering from TBI indicates that the human subject with the head injury is suffering from severe TBI.
